![Robert Glassman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Robert Glassman
Directeur/Membre du Conseil chez
PHARVARIS N.V.
Fortune : 316 680 $ au 31/05/2026
Profil
Robert H.
Glassman currently works at Pharvaris NV, as Independent Non-Executive Director from 2021, Tarus Therapeutics, Inc., as Independent Director from 2021, Jubilant Therapeutics, Inc., as Independent Non-Executive Director from 2021, Umoja Biopharma, Inc., as Director from 2021, Pharvaris GmbH, as Director from 2021, Weill Cornell Medical College, as Clinical Assistant Professor, and Enavate Sciences, as Executive Vice President-Search & Evaluation from 2022.
Dr. Glassman also formerly worked at Credit Suisse Securities (USA) LLC, as Vice Chairman & Managing Director from 2015 to 2021, Bank of America Merrill Lynch (New York), as Managing Director from 2010 to 2015, Portage Biotech, Inc., as Independent Director from 2022 to 2024, Merrill Lynch & Co., Inc., as Principal in 2008, McKinsey & Co., Inc., as Consultant, The Rockefeller University, as Basic Science Investigator, and OrbiMed Advisors Private Equity, as Partner from 2009 to 2010.
Dr. Glassman received his doctorate degree from Harvard Medical School and undergraduate degree from Harvard College.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
PHARVARIS N.V. 0,02 % | 15/05/2026 | 10 500 ( 0,02 % ) | 316 680 $ | 31/05/2026 |
Postes actifs de Robert Glassman
| Sociétés | Poste | Début |
|---|---|---|
| PHARVARIS N.V. | Directeur/Membre du Conseil | 01/01/2021 |
Tarus Therapeutics, Inc.
 Tarus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company focused on nucleotide metabolism in cancer | Directeur/Membre du Conseil | 01/01/2021 |
Pharvaris GmbH
 Pharvaris GmbH Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Directeur/Membre du Conseil | 05/01/2021 |
Umoja Biopharma, Inc.
 Umoja Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals for treatment of cancer therapies | Directeur/Membre du Conseil | 25/01/2021 |
Jubilant Therapeutics, Inc.
 Jubilant Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for oncology and autoimmune diseases | Directeur/Membre du Conseil | 01/02/2021 |
Weill Cornell Medical College
 Weill Cornell Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Enavate Sciences
 Enavate Sciences Financial ConglomeratesFinance Invests and supports therapeutic & enabling technology companies | Private Equity Investor | 11/07/2022 |
Anciens postes connus de Robert Glassman
| Sociétés | Poste | Fin |
|---|---|---|
| ALPHA COMPUTE CORP | Directeur/Membre du Conseil | 26/04/2024 |
Credit Suisse Securities (USA) LLC
 Credit Suisse Securities (USA) LLC Regional BanksFinance Provides investment banking, asset management and securities brokerage services | Directeur/Membre du Conseil | 01/01/2021 |
| ░░░░ ░░ ░░░░░░░ ░░░░░░░ ░░░░░ ░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░ ░░░░░ ░░░░ ░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░░░░░░░░ ░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Formation de Robert Glassman
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
97
Relations au 1er degré
16
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 16 |
|---|---|
Merrill Lynch & Co., Inc. /Old/
 Merrill Lynch & Co., Inc. /Old/ Investment Banks/BrokersFinance Provides wealth management, securities trading and sales, corporate finance and investment banking services | Finance |
AlphaTON Capital Corp.
 AlphaTON Capital Corp. Packaged SoftwareTechnology Services Operates as an AI compute infrastructure company that provides hardware-enforced GPU as a service solutions | Technology Services |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Commercial Services |
The Rockefeller University
 The Rockefeller University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Credit Suisse Securities (USA) LLC
Credit Suisse Securities (USA) LLC Regional BanksFinance Provides investment banking, asset management and securities brokerage services | Finance |
OrbiMed Advisors Private Equity
 OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity invests in companies located across the globe primarily in North America, Asia, Europe and Israel. The firm focuses on biopharmaceuticals, medical technology and healthcare services. It participates in seed-stage, early stage, growth transactions. It also provides debt capital and monetize royalty streams and invests in publicly-traded companies. | Finance |
Weill Cornell Medical College
Weill Cornell Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard College
 Harvard College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pharvaris NV
 Pharvaris NV BiotechnologyHealth Technology Develops and commercializes oral bradykinin B2 receptor antagonists | Health Technology |
Bank of America Merrill Lynch (New York)
 Bank of America Merrill Lynch (New York) Regional BanksFinance Provides corporate, investment banking and wealth management services | Finance |
Tarus Therapeutics, Inc.
Tarus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company focused on nucleotide metabolism in cancer | Health Technology |
Jubilant Therapeutics, Inc.
Jubilant Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for oncology and autoimmune diseases | Health Technology |
Umoja Biopharma, Inc.
Umoja Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals for treatment of cancer therapies | Health Technology |
Pharvaris GmbH
Pharvaris GmbH Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Enavate Sciences
Enavate Sciences Financial ConglomeratesFinance Invests and supports therapeutic & enabling technology companies | Finance |
